Considerations for the Canine Thrombogenicity Test

This white paper proposes a test method that addresses FDA expectations, practical considerations, and inherent limitations of the canine thrombogenicity test.

By Christopher Parker, M.S., M.B.A.

Enter your details below to view the free whitepaper

By downloading this Whitepaper, you acknowledge that Global Data Plc may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Global Data Plc may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.